Curcumin is a yellow pigment found in turmeric (Curcuma Longa L.), and is reported, in recent studies, to have several pharmacological effects, including
anti-oxidant, anti-inflammatory, anti-tumour and
lipid-lowering properties. However, as most
curcumin is conjugated when absorbed through the intestine, free
curcumin is present at extremely low levels inside the body. Therefore,
curcumin metabolites have been presumed to be responsible for the
curcumin bioactivity. In this study, we first confirmed that
curcumin glucuronide is the major metabolite of
curcumin found in the plasma after
oral administration of
curcumin in rats. Next, we synthesised
curcumin glucuronide and compared the effects of
curcumin and
curcumin glucuronide on gene expression in a human
hepatoma cell line (HepG2). We found that the effects of
curcumin glucuronide are weaker than those of
curcumin and that this difference is related to relative absorption rates of
curcumin and
curcumin glucuronide into HepG2 cells.